Ginger: Panacea or Consumer’s Hype?
Source abstract
Abstract
Ginger in its many forms, from juices of the fresh rhizome, to ginger powder and ginger essential oil, is growing in popularity for claimed universal health benefits. Nevertheless, and contrarily to the common notion of the public, ginger is not devoid of side effects, especially interactions with other drugs, and many of the claimed benefits remain to be substantiated. This work presents a comprehensive revision of the current state of the art on ginger pharmacokinetics and bioavailability, interaction with active pharmaceutical ingredients, raising awareness of the risks of uncontrolled ginger consumption. A second section of the work described the verified actions of various extracts of ginger, or of their main active ingredients, gingerols, based mainly on data obtained from controlled clinical trials. Finally, the last section is devoted to innovative technological solutions to improve the bioavailability of gingerols and ginger extracts that are expected to ultimately lead to the development of more consumer-compliant products.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Ginger and Zingiberaceae research · Piperaceae Chemical and Biological Studies · Phytochemistry and biological activity of medicinal plants
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
REQUIMTE/LAQV—Associated Laboratory for Green Chemistry, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
Funding
Fundação para a Ciência e a Tecnologia · European Regional Development Fund
References (97)
Show source-provided references
1. Benzie, I.F.F., and Wachtel-Galor, S. (2011). The Amazing and Mighty Ginger. Herbal Medicine: Biomolecular and Clinical Aspects, CRC Press/Taylor & Francis. [2nd ed.].10.1201/b10787 ↗
2. Some physico-chemical, pharmacological and toxicological properties of ginger (Zingerber officinale)—A review10.1016/j.fct.2007.09.085 ↗
3. Health benefits of herbs and spices: The past, the present, the future10.5694/j.1326-5377.2006.tb00548.x ↗
4. WHO (2018). WHO Monographs on Selected Medicinal Plants—Volume 1. WHO Essential Medicines and Health Products Information Portal, WHO.
5. US Food and Drug Administration (2019, January 28). CFR—Code of Federal Regulations, Title 21—Food and Drugs, Chapter I—Food and Drug Administation, Subchapter B—Food for Human Consumption (continued), Part 182—Substances Generally Recognized as Safe, Subpart A—General Provisions: Sec. 182.20, Available online: https://www.ecfr.gov/cgi-bin/text-idx?SID=dfc2dae5c6f384d423719ba6d29c7c1b&mc=true&node=se21.3.182_120&rgn=div8.
6. Transparency Market Research (2019, January 28). Ginger Market (Form—Fresh, Dried, Pickled, Preserved, Crystallized, and Powdered; Distribution Channel—Modern Grocery Retail, Traditional Grocery Retail, and Non-Grocery Retail; Application—Culinary, Soups and Sauces, Snacks & Convenience Food, Bakery Products, Alcoholic Beverages, Non-Alcoholic Beverages, and Chocolate and Confectionery)—Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017—2022. Available online: https://www.transparencymarketresearch.com/ginger-market.html.
7. Ginger: A Potential Neutraceutical, An Updated Review
8. Schulick, P. (2012). Ginger: Common Spice and Wonder Drug, Hohm Press. [3rd ed.].
9. Commercially processed dry ginger (Zingiber officinale): Composition and effects on LPS-stimulated PGE2 production10.1016/j.phytochem.2005.05.007 ↗
10. Characterization of gingerol-related compounds in ginger rhizome (Zingiber officinale Rosc.) by high-performance liquid chromatography/electrospray ionization mass spectrometry10.1002/rcm.2140 ↗
11. Inhibitors of Prostaglandin Biosynthesis from Ginger10.1248/cpb.30.754 ↗
12. Modulation of macrophage functions by compounds isolated from Zingiber officinale10.1055/s-0028-1088347 ↗
13. Provisional Biopharmaceutical Classification of Some Common Herbs Used in Western Medicine10.1021/mp200162b ↗
14. The Anti-Ulcer Effect in Rats of Ginger Constituents10.1016/0378-8741(88)90009-8 ↗
15. Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress10.3109/09637486.2010.515565 ↗
16. Extraction of Ginger Flavor with Liquid or Supercritical Carbon Dioxide10.1016/0896-8446(95)90028-4 ↗
17. Optimization and Scale-up Process for Supercritical Fluids Extraction of Ginger Oil from Zingiber Officinale Var. Amarum10.1016/j.supflu.2016.05.035 ↗
18. Characterisation of Ginger Extracts Obtained by Subcritical Water
19. Total Synthesis of Natural Gingerols, the Three Active Principles of Ginger10.1021/jo00060a038 ↗
20. Metabolism of [6]-gingerol in rats10.1016/S0024-3205(01)01551-X ↗
21. Mukkavilli, R., Yang, C., Tanwar, R.S., Ghareeb, A., Luthra, L., and Aneja, R. (2017). Absorption, Metabolic Stability, and Pharmacokinetics of Ginger Phytochemicals. Molecules, 22.10.3390/molecules22040553 ↗
22. Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects10.1158/1055-9965.EPI-07-2934 ↗
23. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases10.1002/mnfr.200600283 ↗
24. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy10.1067/S0002-9378(03)00649-5 ↗
25. Safety of ginger use in pregnancy: Results from a large population-based cohort study10.1007/s00228-012-1331-5 ↗
26. Ginger-chemistry, technology, and quality evaluation: Part 2. Crit
27. Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer10.1158/1940-6207.CAPR-11-0224 ↗
28. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease10.1016/S0952-3278(97)90587-1 ↗
29. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects10.1111/j.1365-2125.2005.02322.x ↗
30. Marx, W., McKavanagh, D., McCarthy, A.L., Bird, R., Ried, K., Chan, A., and Isenring, L. (2015). The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review. PLoS ONE, 10.10.1371/journal.pone.0143675 ↗
31. Qazi, G.N., Tikoo, L.C., Gupta, A.K., Ganjoo, K.S., Gupta, D.K., Jaggi, B.S., Singh, R.P., Singh, G., Chandan, K.B., and Suri, K.A. (2003). Bioavailability Enhancing Activity of Zingiber Officinale Linn and Its Extracts/Fractions Thereof. (Patent WO2003049753A1).
32. Bioenhancement effect of piperine and ginger oleo resin on the bioavailability of atazanvir
33. Ginger Significantly Decreased the Oral Bioavailability of Cyclosporine in Rats10.1142/S0192415X06004338 ↗
34. Acute effects of dietary ginger on muscle pain induced by eccentric exercise10.1002/ptr.3148 ↗
35. Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise10.1016/j.jpain.2009.12.013 ↗
36. Analgesic and Anti-Inflammatory Activities of [6]-Gingerol10.1016/j.jep.2004.09.009 ↗
37. A randomized, placebo-controlled, cross-over study of ginger extracts and Ibuprofen in osteoarthritis10.1053/joca.1999.0264 ↗
38. Comparing the effects of ginger (Zingiber officinale) extract and ibuprofen on patients with ostheoarthritis
39. Evaluating the effects of ginger extract on knee pain, stiffness and difficulty in patients with knee osteoarthritis
40. Ginger (Zingiber Officinale) in Migraine Headache10.1016/0378-8741(90)90037-T ↗
41. Hexane fraction of Zingiberis Rhizoma Crudus extract inhibits the production of nitric oxide and proinflammatory cytokines in LPS-stimulated BV2 microglial cells via the NF-kappaB pathway10.1016/j.fct.2009.02.012 ↗
42. Anti-neuroinflammatory capacity of fresh Ginger is attributed mainly to 10-Gingerol10.1016/j.foodchem.2013.06.010 ↗
43. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting10.1186/1475-2891-13-20 ↗
44. Ginger treatment of hyperemesis gravidarum10.1016/0028-2243(91)90202-V ↗
45. The effect of ginger biscuit on nausea and vomiting in early pregnancy
46. Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: A randomized double-blind controlled trial
47. Comparing ginger and vitamin B6 for the treatment of nausea and vomiting in pregnancy: A randomised controlled trial10.1016/j.midw.2007.10.013 ↗
48. Ginger syrup as an antiemetic in early pregnancy
49. Comparing the effects of ginger and metoclopramide on the treatment of Pregnancy nausea10.3923/pjbs.2011.817.820 ↗
50. Effects of ginger capsules on pregnancy, nausea, and vomiting10.1089/acm.2008.0406 ↗
51. A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy
52. A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy10.1097/01.AOG.0000118307.19798.ec ↗
53. A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy
54. Ginger for nausea and vomiting in pregnancy: Randomized, double-masked, placebo-controlled trial
55. Vertigo-reducing effect of ginger root. A controlled clinical study10.1159/000275883 ↗
56. Ginger root against seasickness: A controlled trial on the open sea10.3109/00016488809119444 ↗
57. Motion sickness, ginger, and psychophysics10.1016/S0140-6736(82)92205-X ↗
58. Effects of ginger on motion sickness and gastric slowwave dysrhythmias induced by circular vection10.1152/ajpgi.00164.2002 ↗
59. Effects of ginger on motion sickness susceptibility and gastric function10.1159/000138781 ↗
60. Ginger root—A new aniemetic: The effect of ginger root on postoperative nausea and vomiting after gynaecological surgery10.1111/j.1365-2044.1990.tb14395.x ↗
61. Zingiber officinale (ginger)—An antiemetic for day case surgery10.1111/j.1365-2044.1993.tb07188.x ↗
62. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: A URCC CCOP study of 576 patients10.1007/s00520-011-1236-3 ↗
63. Effects of Inhaled Ginger Aromatherapy on Chemotherapy-Induced Nausea and Vomiting and Health-Related Quality of Life in Women with Breast Cancer10.1016/j.ctim.2015.03.009 ↗
64. Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis
65. Effect of Zingiber officinale R. Rhizomes (ginger) on pain relief in primary dysmenorrhea: A placebo randomized trial10.1186/1472-6882-12-92 ↗
66. The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: A randomized clinical trial10.1007/s00404-014-3548-2 ↗
67. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea10.1089/acm.2008.0311 ↗
68. Effect of progressivemuscle relaxation versus intake of ginger powder on dysmenorrhoea amongst the nursing students in Pune10.48029/NJI.2012.CIII401 ↗
69. Anti-inflammatory effects of Zingiber officinale in type 2 diabetic patients
70. The effect of Ginger consumption on some cardiovascular risk factors in patients with type 2 diabetes mellitus
71. The effect of Ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus10.3109/09637486.2014.880671 ↗
72. Effect of Aswagandha, Ginger and Mulberry on Hyperglycemia and Hyperlipidemia10.1023/B:QUAL.0000040352.23559.04 ↗
73. The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial10.1016/j.ctim.2013.12.017 ↗
74. Effects of 10 week resistance training and ginger consumption on C-reactive protein and some cardiovascular risk factors in obese men
75. Effects of ginger on serum glucose, advanced glycation end products, and inflammation in peritoneal dialysis patients10.1016/j.nut.2014.11.020 ↗
76. Effects of Ginger Supplementation on Cell Cycle Biomarkers in the Normal-Appearing Colonic Mucosa: Results from a Pilot, Randomized, Controlled Trial10.1158/1940-6207.CAPR-12-0327 ↗
77. Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer10.1097/CEJ.0b013e32835c829b ↗
78. Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trial10.1016/j.ctim.2013.12.015 ↗
79. Rahimlou, M., Yari, Z., Hekmatdoost, A., Alavian, S.M., and Keshavarz, S.A. (2016). Ginger supplementation in nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled pilot study. Hepatitis Mon., 16.10.5812/hepatmon.34897 ↗
80. Effect of Zingiber officinale supplementation on obesity management with respect to the uncoupling protein 1-3826A>G and β3-adrenergic receptor Trp64Arg polymorphism10.1002/ptr.5343 ↗
81. Changes of serum adipocytokines and bodyweight following Zingiber officinale supplementation in obese women: A RCT10.1007/s00394-015-1027-6 ↗
82. Microencapsulated ginger oil properties: Influence of operating parameters10.1080/07373937.2016.1231690 ↗
83. Microencapsulation and Oxidative Stability of Ginger Essential Oil in Maltodextrin/Whey Protein Isolate (MD/WPI)10.3923/ijds.2007.387.392 ↗
84. Microencapsulation Technology of Ginger Oleoresin with Chitosan as Wall Material: A review10.7324/JAPS.2016.601232 ↗
85. Encapsulation of red ginger oleoresin (Zingiber officinale var rubrum) with chitosan as wall material10.22159/ijpps.2017v9i8.15632 ↗
86. Encapsulation Red Ginger Oleoresin (Zingiber officinale var. Rubrum) with Chitosan-alginate as Wall Material Using Spray Drying10.19026/rjaset.10.1836 ↗
87. Analysis of Chemical Properties of Edible and Medicinal Ginger by Metabolomics Approach10.1155/2015/671058 ↗
88. Purathrive (2019, March 12). Could Ginger Be Used Medicinally?. Available online: https://purathrive.com/could-ginger-be-used-medicinally.
89. Synchro (2019, March 12). Gold (Lemon ginger). Available online: https://besynchro.com/collections/shop/products/synchro-gold-lemon-ginger.
90. Encapsulation of ginger ethanolic extract in nanoliposome and evaluation of its antioxidant activity on sunflower oil10.1007/s11696-017-0164-1 ↗
91. Study on improving bioavailability ratio of anti-inflammatory compound from ginger through nano transdermal delivery
92. Grape exosomelike nanoparticles induce intestinal stem cells and protect mice from dss-induced colitis10.1038/mt.2013.64 ↗
93. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit10.1038/mt.2013.190 ↗
94. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles10.1002/mnfr.201300729 ↗
95. Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis10.2217/nnm-2017-0196 ↗
96. Ginger-derived nanoparticles protect against alcohol-induced liver damage10.3402/jev.v4.28713 ↗
97. Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy10.1038/mt.2016.159 ↗